Zhongxin fluoromaterials: it is planned to acquire 51% equity of Jiangxi Exxon through equity transfer and cash capital increase
Zhongxin fluoro materials announced that it plans to acquire 51% of the equity of Jiangxi Exxon chemical materials Co., Ltd. with RMB 357million through equity transfer and cash capital increase. The existing business of the subject company belongs to the fluorine-containing refrigerant industry.
This text is a result of machine translation.
Related companies：
In-depth
Technology
The Next Crossroad of SaaS: Vertical or Horizontal?
The SaaS (Software as a Service) industry has developed in China over nearly three decades. From horizontal SaaS formats to Vertical SaaS, great changes have taken place. Now the SaaS industry has entered a boom stage.
Sep 13, 2022 12:38 PM
Tianci materials: it is planned to buy back the company's shares of RMB 250million to RMB 500million
Briefing May 18, 2022 11:24 AM
· Technology
Lithium battery stocks continued to strengthen, and Edison raised the sealing plate
Aug 29, 2022 05:45 PM
Aug 09, 2022 04:42 PM
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Briefing Mar 10, 2022 09:38 AM
· Technology
Lithium battery stocks rose sharply at the opening, and Meilian new material 20cm trading limit
Technology
Cloud Service Firm Realibox Raises CNY 100 Mn from Series A financing round
Realibox(Chinese:引力波), a cloud-native 3D digital assets' entire lifecycle collaborative platform provider, announced its Series A financing round worth CNY 100 million(USD 13.9 million), with participation by Chengwei Capital, GL Ventures, Vision Capital, and Kaitai Capital.
Updated 5 hours ago
Technology
Optoelectronic Chip Firm Luxic Bags Hundreds of Mns of CNY
Luxic is a high-speed optoelectronic chip designer. It recently completed two rounds of funding worth hundreds of millions of CNY, which Pre-Series A funding round was led by Source Code Capital and Series A financing round was led by China Fortune-Tech Capital.
Yesterday 03:39 PM
Briefing Feb 08, 2022 09:49 AM
The infrastructure sector continued to strengthen
Briefing Jan 23, 2022 05:59 PM
· Healthcare
Kangtai biology: CDE starts the on-site verification of the registration of freeze-dried human rabies vaccine (human diploid cells)
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth